Everest Organics Limited (EVERESTO.BO)
INR 402.45
(3.13%)
INR 402.45
(3.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 118.72 Million INR | 1031.01% |
| 2022 | 78.73 Million INR | -85.14% |
| 2021 | 86.38 Million INR | -71.44% |
| 2020 | 239.04 Million INR | 3.88% |
| 2019 | 206.16 Million INR | 23.57% |
| 2018 | 183.76 Million INR | 151.86% |
| 2017 | 77.82 Million INR | 17.86% |
| 2016 | 69.86 Million INR | -3.3% |
| 2015 | 62.12 Million INR | -22.06% |
| 2014 | 79.71 Million INR | 38.41% |
| 2013 | 57.59 Million INR | 6.42% |
| 2012 | 54.12 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -36.57 Million INR | -202.32% |
| 2023 Q4 | 29.59 Million INR | 5.76% |
| 2023 Q3 | 27.98 Million INR | -4.98% |
| 2023 FY | - INR | 1031.01% |
| 2023 Q1 | 25.21 Million INR | 10.61% |
| 2023 Q2 | 29.45 Million INR | 16.79% |
| 2022 FY | - INR | -85.14% |
| 2022 Q1 | -12.48 Million INR | -171.7% |
| 2022 Q2 | 29.93 Million INR | 339.84% |
| 2022 Q3 | -24.9 Million INR | -183.19% |
| 2022 Q4 | 22.79 Million INR | 191.55% |
| 2021 Q3 | 16.61 Million INR | 239.67% |
| 2021 Q1 | 42.14 Million INR | -2.45% |
| 2021 FY | - INR | -71.44% |
| 2021 Q2 | -11.89 Million INR | -128.23% |
| 2021 Q4 | 17.4 Million INR | 4.75% |
| 2020 Q4 | 43.2 Million INR | -29.49% |
| 2020 FY | - INR | 3.88% |
| 2020 Q3 | 61.27 Million INR | -6.29% |
| 2020 Q2 | 65.39 Million INR | 5.45% |
| 2020 Q1 | 62.01 Million INR | -17.49% |
| 2019 FY | - INR | 23.57% |
| 2019 Q2 | 45.25 Million INR | -28.48% |
| 2019 Q1 | 63.27 Million INR | 15.27% |
| 2019 Q3 | 43.19 Million INR | -4.56% |
| 2019 Q4 | 75.15 Million INR | 74.01% |
| 2018 Q3 | 57.86 Million INR | 31.92% |
| 2018 Q2 | 43.86 Million INR | 79.12% |
| 2018 Q1 | 24.48 Million INR | 87.03% |
| 2018 Q4 | 54.89 Million INR | -5.14% |
| 2018 FY | - INR | 151.86% |
| 2017 Q1 | 18.51 Million INR | 32.29% |
| 2017 Q4 | 13.09 Million INR | -32.85% |
| 2017 FY | - INR | 17.86% |
| 2017 Q3 | 19.49 Million INR | -9.68% |
| 2017 Q2 | 21.59 Million INR | 16.59% |
| 2016 Q4 | 13.99 Million INR | -26.6% |
| 2016 FY | - INR | -3.3% |
| 2016 Q1 | 15.42 Million INR | -52.84% |
| 2016 Q2 | 16.92 Million INR | 9.67% |
| 2016 Q3 | 19.06 Million INR | 12.7% |
| 2015 Q1 | 16.86 Million INR | -42.3% |
| 2015 Q3 | 12.93 Million INR | 31087.43% |
| 2015 Q2 | -41.75 Thousand INR | -100.25% |
| 2015 Q4 | 32.71 Million INR | 152.85% |
| 2015 FY | - INR | -22.06% |
| 2014 Q4 | 29.22 Million INR | 70.43% |
| 2014 Q3 | 17.14 Million INR | 11.44% |
| 2014 FY | - INR | 38.41% |
| 2014 Q2 | 15.38 Million INR | 0.0% |
| 2013 Q4 | 10.02 Million INR | -28.24% |
| 2013 Q1 | 16.12 Million INR | 142.87% |
| 2013 Q3 | 13.97 Million INR | -14.5% |
| 2013 FY | - INR | 6.42% |
| 2013 Q2 | 16.34 Million INR | 1.4% |
| 2012 FY | - INR | 0.0% |
| 2012 Q4 | 6.63 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 36.55 Million INR | -224.763% |
| Checkpoint Trends Limited | 297.07 Thousand INR | -39866.001% |
| GUJARAT INJECT (KERALA) LTD. | 1.05 Million INR | -11179.093% |
| NATURO INDIABULL LIMITED | 14.68 Million INR | -708.382% |
| NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | -3881.54% |
| Rajnish Wellness Limited | 19.93 Million INR | -495.451% |
| Rama Vision Limited | 67.79 Million INR | -75.132% |
| Vivo Bio Tech Limited | 212.99 Million INR | 44.259% |